Randomised controlled trial of ondansetron in smoking cessation

Psychopharmacology

Volumn 126, Issue 1, 1996, Pages 95-96

  West, Robert ^a   Hajek, Peter ^b  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

Cigarette withdrawal; Ondansetron; Smoking

Indexed keywords

NICOTINE; ONDANSETRON; SEROTONIN 3 RECEPTOR;

ABSTINENCE; ADULT; ANXIETY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION; TRANQUILIZING ACTIVITY;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; NICOTINE; ONDANSETRON; SEROTONIN ANTAGONISTS; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0029892543     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02246417     Document Type: Article

References (7)

1. Cropp CD, Goraharper ML (1995) Ondansetron use for smoking cessation. Ann Pharmacother 29: 1041-1042
2. 3 receptors in drug dependence. Drug Alcohol Depend 38: 155-171
3. Hajek P (1994) Helping smokers to overcome tobacco withdrawal: background and practice of withdrawal-oriented therapy. In: Richmond R (ed) Interventions for smokers: an international perspective. Wilkins, New York, pp 29-46
4. Hughes J (1994) Non-nicotine pharmacotherapies for smoking cessation. J Drug Dev 6: 196-203
5. Silagy C, Mant D, Fowler G, Lodge M (1994) Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet 343: 139-142
6. West R, Hajek P, McNeill A (1991) Effect of buspirone on cigarette withdrawal symptoms and short-term abstinence rates in a smokers clinic. Psychopharmacology 104: 91-96
7. Zacny JP, Apfelbaum JL, Lichtor JL, Zarqagoza JG (1993) Effects of 5-hydroxytryptamine 3 antagonist, ondansetron, on cigarette smoking, smoke exposure and mood in humans. Pharmacol Biochechem Behav 44: 387-391